FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/12/2026
Back to search
Official data from USPTO
AXPLORA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AXPLORA
ST13
US500000079364601Class
1, 3, 5, 40, 42
Filing
79364601
Registration
7813324
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 3, 5, 40, 42
Filing date
11/30/2022
Registration date
06/03/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
UKAOMA, ULOMA JANET
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Axplora Group GmbH
Representatives
B. Michelle Alvey Husch Blackwell LLP
Technical classification
Nice Classes
Class 1Class 3Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products in the nature of chemicals for use in industry and sciencespecifically for the pharmaceuticalcosmeticsagrochemistryfoodpolymers industries; biochemical catalystscatalysts for chemical and biochemical processescatalysts for use in the manufacture of industrial chemicals; chemical additiveschemical additives for use in the manufacture of foodchemical additives for use in the manufacture of pharmaceuticalschemical additives for use in the manufacture of cosmeticschemical additives for gasoline; biochemical reagents used for non-medical purposeschemical reagentsother than for medical or veterinary purposesreagents for scientific and research useresearch reagents for industrial usefor food testingchemical diagnostic reagents for industrial use; intermediate products of synthesischemicals used in industryintermediate products for the cosmeticpharmaceuticalagrochemistryfoodpolymers industries; active principlesactive chemical ingredients for use in the manufacture of pharmaceuticalsagrochemicalsexplosives; fertilizers; all of the foregoing for use in the pharmaceuticalcosmeticsagrochemistryfoodpolymers industries; intermediary products for the synthesis of pharmaceuticalveterinarysanitary and cosmetic active principleschemical products being synthesized pharmaceutical intermediates for the production of active pharmaceutical ingredients used in the manufacture of pharmaceuticals
Class 3
Purified essential oil extracts for use in the pharmaceuticalcosmeticsagrochemistryfoodpolymers industries
Class 5
Pharmaceuticalveterinarysanitary productssteroidsdiuretic preparationsanti-inflammatory preparationsdietary supplementsnutritional supplementsdiagnostic agents for medical purposes being visualization agents for use during colonoscopiescontraceptive preparationspreparations for the treatment of burnspharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agentpharmaceutical preparations and substances for the treatment of metabolicendocrinemusculoskeletalcardiovascularcardiopulmonaryoncologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalimmune system related diseases and disorders; fungicidesherbicidesinsecticidespesticides
Class 40
Custom manufacturing of pharmaceutical and chemicals and their components; contract and toll custom manufacturing in the fields of pharmaceuticalschemicals and biotechnology; preparation and transformation being custom manufacture of vaccine adjuvantsvaccinesproteinssemi-synthetic moleculesconjugated moleculesnucleic acidspolysaccharides and other therapeutic biomolecules; preparation and transformation being custom manufacture on a pilot and commercial scale of vaccine adjuvantsvaccinesproteinssemi-synthetic moleculesconjugated moleculesnucleic acidspolysaccharidesother therapeutic biomolecules; preparation being processing of functional food and food ingredients; pilot and commercial scale preparation being processing of functional food and food ingredients; preparation and transformation being custom manufacture of chemical productsactive pharmaceutical ingredients and synthetic intermediatesagrochemical active ingredients and synthetic intermediates; preparation and transformation being custom manufacture on a pilot and commercial scale of chemical productsactive pharmaceutical ingredients and synthetic intermediatesagrochemical active ingredients and synthetic intermediates
Class 42
Providing quality controlanalytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing productsnotably for the foodchemicalagricultureveterinarypharmaceutical industries; scientific research and development in the field of performance of chemical synthesis for others; biological researchsynthesis of biological products for clients operating in the foodchemicalagricultureveterinarypharmaceutical fields; scientific research and development in the field of synthesis of intermediate productsnotably of intermediate organic products for industrial purposesnotably for the foodchemicalagricultureveterinarypharmaceutical industries; scientific research and development in the field of synthesis of hazardous productssynthesis of substitution aromates and chiral moleculesnotably synthesis of products for others; scientific research in the field of into galenic formsspecifically for others; preparation of galenic formulationsspecifically for others
Publications
History of USPTO decisions and trademark events.
40 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/30/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
12/30/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/03/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
04/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/19/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/23/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/29/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/29/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/13/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2024
GNRT
NON-FINAL ACTION E-MAILED
08/07/2024
CNRT
NON-FINAL ACTION WRITTEN
08/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2024
RFNT
REFUSAL PROCESSED BY IB
10/25/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/02/2023
RFRR
REFUSAL PROCESSED BY MPU
10/02/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/20/2023
CNRT
NON-FINAL ACTION WRITTEN
09/19/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
08/06/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
06/05/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/09/2023
Continuous trademark protection
Get notified about every new filing that threatens AXPLORA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.